Driven by technological advances and the desire to characterize biological systems more fully, research combining multiple types of omics data has become increasingly common. Such multiomics efforts include both individual labs as well as major initiatives like the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and diagnostics companies such as PrognomiQ.
Read the full article on GenomeWeb here.
